Eiken Licenses LAMP to OptiGene, UK's Veterinary Laboratories Agency | GenomeWeb

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – OptiGene today announced an agreement to license Eiken Chemical's LAMP gene amplification technology.

Separately, Eiken this week said that it also is licensing the technology to the UK Veterinary Laboratories Agency.

As part of its agreement, OptiGene will develop, manufacture, and sell nucleic acid amplification reagents for research use.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.